A cautionary tale: Anaphylaxis to isosulfan blue dye after 12 years and 3339 cases of lymphatic mapping

American Surgeon

Volumn 74, Issue 2, 2008, Pages 152-155

  Kaufman, Gabriel ^a   Guth, Amber A ^a,b   Pachter, H Leon ^a   Roses, Daniel F ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOSULFAN BLUE; TRACER;

ADULT; AGED; ANAPHYLAXIS; ARTICLE; BREAST CANCER; CANCER STAGING; CASE REPORT; EARLY CANCER; FEMALE; HUMAN; HYPOTENSION; LYMPH NODE METASTASIS; LYMPHATIC SYSTEM; MALE; MELANOMA; SENTINEL LYMPH NODE BIOPSY; TACHYCARDIA;

AGED; ANAPHYLAXIS; COLORING AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY; TIME FACTORS;

EID: 40949153375     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Roses DF. Breast Cancer. 2nd ed. Philadelphia: Elsevier; 2005.
2. Cabanas RM. An approach for the treatment of penile cancer. Cancer 1977;39:456-66.
3. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
4. Guiliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345.
5. Albo D, Wayne JD, Hunt KK, et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg 2001;182:393-8.
6. Efron P, Knudsen E, Hirshorn S, et al. Anaphylactic reaction to isosulfan blue dye used for sentinel node biopsy: case report and literature review. Breast J 2002;8:396-9.
7. Dewachter P, Mounton-Faivre C, Trechot P, et al. Severe anaphylactic shock with methylene blue instillation. Anesth Analg 2005;101:149-50.
8. Kuerer HM, Wayne JD, Ross MI. Anaphylaxis during breast cancer lymphatic mapping. Surgery 2001;129:119-20.
9. Komenaka IK, Bauer VP, Schnabel FR, et al. Allergic reactions to isosulfan blue in sentinel node mapping. Breast J 2005;11:70-2.
10. Montgomery LL, Thorne AC, Van Zee KJ, et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg 2002;95:385-8.
11. Lyew MA, Gamblin TC, Ayoub M. Systemic anaphylaxis associated with intramammary isosulfan blue injection used for sentinel node detection under general anesthesia. Anesthesiology 2000;93:1145-6.
12. Laurie SA, Khan DA, Gruchalla RS, et al. Anaphylaxis to isosulfan blue. Ann Allergy Asthma Immunol 2002;88:64-6.
13. Raut CP, Hunt KK, Akins JS, et al. Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis. Cancer 2005;104:692-9.
14. Thevarajah S, Huston TL, Simmons RM. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg 2005;189:236-9.
15. Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 2006;13:491-500.
16. Zakaria S, Hoskin T, Degnim AC. Safety of methylene blue dye for lymphatic mapping in breast cancer. Poster #P195. Ann Surg Oncol 2007;14(suppl):S-90.
17. Eldrageely K, Vargas MP, Khalkhali I, et al. Sentinel lymph node mapping of breast cancer. Am J Surg 2004;70:872-5.
18. Blessing WD, Stolier AJ, Teng SC, et al. A comparison of methylene blue and Lymphazurin in breast cancer sentinel node mapping. Am J Surg 2002;184:341-5.
19. Golshan M, Nakhlis F. Can methylene blue only be used in sentinel lymph node biopsy for breast cancer? Breast J 2006;12:428-30.
20. Masannat Y, Shenoy H, Speirs V, et al. Properties and characteristics of the dyes injected to assist axillary sentinel node localization in breast surgery. Eur J Surg Oncol 2006;32:381-4.
21. Masannat Y, Shenoy H, Speirs V, et al. Properties and characteristics of the dyes injected to assist axillary sentinel node localization in breast surgery. Eur J Surg Oncol 2006;32:381-4.
22. Keller B, Yawalkar N, Pichler C, et al. Hypersensitivity reaction against patent blue dye during sentinel node removal in three melanoma patients. Am J Surg 2007;193:122-4.
23. Kwok ES, Howes D. Use of methylene blue in sepsis: a systemic review. J Intensive Care Med 2006;21:359-63.
24. Salhab M, Sarakbi W, Mokbel K. Skin and fat necrosis of the breast following methylene blue injection for sentinel node biopsy in a patient with breast cancer. International Seminars in Surgical Oncology 2005;2:26.
25. Leong SP, Donegan E, Heffernon W, et al. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol 2000;7:361-6.
26. Cimmino VM, Brown AC, Szocik JF, et al. Allergic reactions to isosulfan blue during sentinel node biopsy - a common event. Surgery 2001;130:439-42.
27. Wrightson WR, Wong SL, Edwards MJ, et al. Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol 2003;10:676-80.